Cervical Adenosquamous Cell Carcinoma Completed Phase 1 Trials for Gemcitabine (DB00441)

Also known as: Cervical Adenosquamous Carcinoma / Adenosquamous carcinoma of the cervix / Adenosquamous carcinoma of cervix (disorder)

IndicationStatusPhase
DBCOND0034091 (Cervical Adenosquamous Cell Carcinoma)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00068549Radiation Therapy Plus Cisplatin and Gemcitabine in Treating Patients With Cervical CancerTreatment